Scientific News Boston Scientific Sees Success In Pfa Device Trial
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Sees Success In Pfa Device Trial is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific Corp (BSX) Secures FDA Labeling Expansion for FARAPULSE Pulsed Field Ablation (PFA) System
Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks. On July 7, Boston Scientific (NYSE:BSX) saw its shares rise as TD Cowen reaffirmed its Buy rating and $115 ... Read More
Boston Scientific, Siemens Healthineers partner on cardiac catheter
Intended for use in structural heart procedures, the cardiac imaging catheter is expected to drive growth for Boston Scientific’s Watchman device. Read More
Analysts project durable growth with many near-term catalysts for Boston Scientific
Analysts remain high on Boston Scientific after a visit to the company's Marlborough, Massachusetts headquarters. Read More
Boston Scientific Keeps Applying Pressure in the PFA Market
The competition in the pulsed-field ablation market has become more intense. Boston Scientific has raised the bar - by winning FDA approval for Farapulse PFA to be used in the treatment of drug ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus